Phenotypic Variation in Patients Heterozygous for Familial Defective Apolipoprotein B (FDB) in Three European Countries
Overview
Authors
Affiliations
A glutamine-for-arginine substitution at amino acid position 3500 of apolipoprotein B (apo B) causes synthesis of LDL with reduced binding affinity to the LDL receptor (LDLR). The associated clinical syndrome has been named familial defective apolipoprotein B- 100 (FDB). In 205 FDB patients from Germany (n = 73). The Netherlands (n = 87), and Denmark (n = 45), we tried to assess determinants of variation in lipid concentrations. Besides age, sex, and geographic origin, variation in the LDLR gene was the most powerful determinant of variation in total cholesterol and LDL cholesterol levels. Polymorphic variation in the LDLR gene (SfaNI, exon 2; Nco I, exon 18) was associated with total cholesterol (TC) and LDL cholesterol (LDL-C) variation in women (SfaNI: P = .04 and .03 for TC and LDL-C, respectively; Nco I; P = .003 and .006, respectively), whereas the Ava II (exon 13) and the Pvu II (intron 15) polymorphisms were not. Combined information from all three LDLR exon polymorphisms showed that subjects with at least one S + A + N + allele had 13% to 20% higher TC than non-S + A + N + subjects (P = .02 [TC, men]; P = .01 [LDL-C, men]; P = .005 [TC, women]; and P = .004 [LDL-C, women]) and, together with age and geographic origin, accounted for 20% (women) and 19% (men) of the variation in LDL-C. The expected association of the apo E genotypes (e3e2, e3e3, and e3e4) with cholesterol concentrations was seen in S + A + N + but not in non-S + A + N + subjects and in P-P- but not in P + P + or P + P- subjects. With regard to clinical expression, FDB patients had lower TC and LDL-C levels and a lower prevalence of cardiovascular disease than 101 Danish patients with familial hypercholesterolemia.
Wang J, Jia K, Guo Q, Liu J, Cai J, Shen Y Int J Mol Sci. 2023; 24(10).
PMID: 37240367 PMC: 10219455. DOI: 10.3390/ijms24109016.
Whole-genome resequencing of Japanese whiting ( ) provide insights into local adaptations.
Han Z, Guo X, Liu Q, Liu S, Zhang Z, Xiao S Zool Res. 2021; 42(5):548-561.
PMID: 34327887 PMC: 8455465. DOI: 10.24272/j.issn.2095-8137.2021.116.
Rojas C, Ramirez H, Salazar L, Kalergis A, Galvez A, Escobar-Vera J J Clin Lab Anal. 2019; 33(9):e23001.
PMID: 31441123 PMC: 6868413. DOI: 10.1002/jcla.23001.
Genetic testing for a patient with suspected familial hypercholesterolaemia.
Mudgundi V, Williams G, Manou K, Block R BMJ Case Rep. 2018; 2018.
PMID: 30030251 PMC: 6058112. DOI: 10.1136/bcr-2018-225259.
The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.
Regina Delicato de Almeida E, Reiche E, Kallaur A, Flauzino T, Watanabe M Biomed Res Int. 2013; 2013:836790.
PMID: 24319689 PMC: 3844249. DOI: 10.1155/2013/836790.